Overview
- Integrated practical and theoretical trends
- Describes fibrinolytic microbial enzymes for clinical applications
- Provides an outlook to future research
- Includes supplementary material: sn.pub/extras
Part of the book series: SpringerBriefs in Microbiology (BRIEFSMICROBIOL)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (1 chapter)
Keywords
About this book
Stress, high blood pressure, smoking, pollution, fast foods, overweight, excessive travelling, surgery, less movement are common features in our modern life. These features are risky for blood clotting disorders. According to WHO, over 29% of the total mortalities worldwide are due to thrombosis. By the year, 2020 cardiovascular diseases (CVDs) may cause an estimated 25 million deaths per year, thus antithrombotic therapy is of great interest.
The available thrombolytic agents such as urokinase are highly expensive, antigenic, quite unspecific, pyretogenic and hemorrhagenic. Therefore, the production of fibrinolysing enzymes, which rapidly dissolute thrombi within the vascular tree, without the detriments by microorganisms, as described in this book, is the desirable aim of today’s research.
Authors and Affiliations
Bibliographic Information
Book Title: Fibrinolytic Bacterial Enzymes with Thrombolytic Activity
Authors: Essam Kotb
Series Title: SpringerBriefs in Microbiology
DOI: https://doi.org/10.1007/978-3-642-24980-8
Publisher: Springer Berlin, Heidelberg
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Essam Kotb 2012
Softcover ISBN: 978-3-642-24979-2Published: 05 January 2012
eBook ISBN: 978-3-642-24980-8Published: 04 January 2012
Series ISSN: 2191-5385
Series E-ISSN: 2191-5393
Edition Number: 1
Number of Pages: XII, 74
Number of Illustrations: 9 b/w illustrations, 6 illustrations in colour
Topics: Medical Microbiology, Hematology, Cardiology, Human Physiology